EMA — authorised 2 September 1999
- Marketing authorisation holder: Sanofi-aventis Deutschland GmbH
- Status: approved
EMA authorised Arava on 2 September 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 2 September 1999.
Sanofi-aventis Deutschland GmbH holds the EU marketing authorisation.